home / stock / xtlb / xtlb news

XTLB News and Press, XTL Biopharmaceuticals Ltd.

Stock Information
Company Name: XTL Biopharmaceuticals Ltd.
Stock Symbol: XTLB
Market: NASDAQ
Website: xtlbio.com
Menu
XTLB XTLB Quote XTLB Short XTLB News XTLB Articles XTLB Message Board
Get XTLB Alerts

News, Short Squeeze, Breakout and More Instantly...
XTLB - XTL announces receipt of staff delisting letter from Nasdaq

2026-02-27 16:43:29 ET More on XTL Biopharmaceuticals Seeking Alpha’s Quant Rating on XTL Biopharmaceuticals Financial information for XTL Biopharmaceuticals Read the full article on Seeking Alpha For further details see: XTL announces receipt of s...
XTLB - XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing

RAMAT GAN, ISRAEL, Feb. 27, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Letter”) from The Listing Qualifications Department (the “St...

XTLB - XTL Update on Recent Developments

RAMAT GAN, ISRAEL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “ Company ” or “ XTL ”), announced that it is working diligently to close the acquisition of 85% of the shares of NeuroNOS Ltd. from Beyond Air Inc, follo...

XTLB - XTL announces receipt of Nasdaq notification

2026-01-23 16:25:39 ET More on XTL Biopharmaceuticals Seeking Alpha’s Quant Rating on XTL Biopharmaceuticals Financial information for XTL Biopharmaceuticals Read the full article on Seeking Alpha For further details see: XTL announces receipt of N...
XTLB - XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

RAMAT GAN, ISRAEL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “ Company ” or “ XTL ”), announced today that it has received a notification letter from The Listing Qualifications Department of The Nasdaq Stock Market ...

XTLB - US Companies Moving the Markets, Morning edition
Wed, Jan 14, 2026 as of 10.00 am ET

A look at the top 10 most actives in the United States Oriental Culture Holding LTD (OCG) fell 33.1% to $0.0113 on volume of 487,792,738 shares Beyond Air Inc. (XAIR) rose 150.0% to $2.19 on volume of 408,605,506 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 2.2% to $2.27 o...

XTLB - US Companies Moving the Markets, Evening edition
Tue, Jan 13, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States Beyond Air Inc. (XAIR) rose 143.7% to $2.135 on volume of 377,501,180 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 2.6% to $2.26 on volume of 344,067,483 shares Strive Inc. (ASST) fell 12.6% to $0.961 on volume of 313,...
XTLB - Morning Market Brief: From IP Land Grabs to FDA Greenlights, Small-Cap Innovation Takes Center Stage

2026-01-13 09:38:22 ET Denver, Colorado- Markets open with a clear signal from the micro- and small-cap arena: intellectual property, regulatory momentum, and platform scalability are driving value creation well ahead of broad risk appetite. BriaCell Therapeutics (NASDAQ:BCTX): Durabl...

XTLB - XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying therapies exist FDA Orphan Drug designations secured for autism-related Phelan...

XTLB - XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying therapies exist FDA Orphan Drug designations secured for autism-related Phelan...
Next 10